Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-20 7:55 pm Unchanged |
2025-03-18 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 15.000% |
0 (Unchanged) |
Filing History |
| 2025-02-14 6:04 pm Sale |
2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 1,266,457 1.400% |
-6,410,477 (-83.50%) |
Filing History |
| 2025-02-14 11:21 am Purchase |
2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Frazier Life Sciences Public Fund, L.P. | 10,664,774 11.900% |
3,283,684 (+44.49%) |
Filing History |
| 2025-02-13 4:01 pm Sale |
2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 4,205,129 4.710% |
-821,802 (-16.35%) |
Filing History |
| 2025-02-13 1:41 pm Purchase |
2025-02-13 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 1,062,500 1.200% |
312,500 (+41.67%) |
Filing History |
| 2024-11-14 5:51 pm Purchase |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 7,676,934 9.990% |
969,370 (+14.45%) |
Filing History |
| 2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 5,026,931 6.920% |
-657,489 (-11.57%) |
Filing History |
| 2024-11-08 6:57 pm Unchanged |
2024-11-06 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 18.700% |
0 (Unchanged) |
Filing History |
| 2024-11-06 10:30 am Purchase |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Frazier Life Sciences Public Fund, L.P. | 7,381,090 10.200% |
717,500 (+10.77%) |
Filing History |
| 2024-10-23 2:44 pm Sale |
2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 750,000 1.030% |
-641,577 (-46.10%) |
Filing History |
| 2024-07-11 5:52 pm Purchase |
2024-06-28 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 1,391,577 1.980% |
465,561 (+50.28%) |
Filing History |
| 2024-07-10 4:16 pm Sale |
2022-05-12 | 13G | Trevi Therapeutics, Inc. TRVI |
MAI Capital Management | 1,519,650 2.200% |
-21,821 (-1.42%) |
Filing History |
| 2024-05-21 6:34 pm Purchase |
2024-05-07 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 20.300% |
703,704 (+4.90%) |
Filing History |
| 2024-04-25 7:39 pm Sale |
2024-03-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 926,016 1.340% |
-1,573,977 (-62.96%) |
Filing History |
| 2024-02-14 8:47 pm Purchase |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 6,707,564 9.990% |
395,372 (+6.26%) |
Filing History |
| 2024-02-14 3:48 pm Sale |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Fairmount Funds Management LLC | 0 0.000% |
-6,018,465 (Position Closed) |
Filing History |
| 2024-02-14 10:21 am Purchase |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
VIKING GLOBAL INVESTORS LP | 6,599,062 9.990% |
436,700 (+7.09%) |
Filing History |
| 2024-02-12 06:06 am Unchanged |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 5,684,420 8.900% |
0 (Unchanged) |
Filing History |
| 2023-02-15 1:16 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 2,499,993 4.200% |
314,329 (+14.38%) |
Filing History |
| 2023-02-14 4:55 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 6,312,192 9.990% |
2,643,858 (+72.07%) |
Filing History |